LIMN (Liminatus Pharma) Float Percentage Of Total Shares Outstanding: 75.58% (As of Jul. 01, 2026)


LIMN Liminatus Pharma Inc LIMN
13 GF Score
Price $0.12
! 1 Warning Sign
View Full Analysis

What is Liminatus Pharma Float Percentage Of Total Shares Outstanding?

Liminatus Pharma LIMN +3.99% 13 Float Percentage Of Total Shares Outstanding is 75.58% as of Jul. 01, 2026. GuruFocus rates LIMN with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Liminatus Pharma's float shares is 38.25 Mil. Liminatus Pharma's total shares outstanding is 50.61 Mil. Liminatus Pharma's float percentage of total shares outstanding is 75.58%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Liminatus Pharma's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Liminatus Pharma's Institutional Ownership is 3.45%.

LIMN
13GF Score
Liminatus Pharma Inc LIMN
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Liminatus Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Liminatus Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=38.25/50.61
=75.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 75.58% mean?
Liminatus Pharma (LIMN) has a Float Percentage Of Total Shares Outstanding of 75.58% as of Jul. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Liminatus Pharma and its competitors.
Is Liminatus Pharma's Float Percentage Of Total Shares Outstanding too high?
Liminatus Pharma's current Float Percentage Of Total Shares Outstanding is 75.58%. Overall, Liminatus Pharma has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Liminatus Pharma's Float Percentage Of Total Shares Outstanding compare to GNPX and PCSA?
Liminatus Pharma's Float Percentage Of Total Shares Outstanding of 75.58% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Liminatus Pharma and its competitors. Liminatus Pharma's current Float Percentage Of Total Shares Outstanding is 75.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liminatus Pharma stock overvalued right now?
Liminatus Pharma (LIMN) has a current Float Percentage Of Total Shares Outstanding of 75.58%. The current Float Percentage Of Total Shares Outstanding is 75.58%. Liminatus Pharma's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Liminatus Pharma (LIMN), the current Float Percentage Of Total Shares Outstanding is 75.58% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Liminatus Pharma Business Description

Address 12611 Hiddencreek Way, Unit C, Cerritos, CA, USA, 90703
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.
13GF Score

Get the complete analysis for LIMN

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price